# Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/developing-covalent-protein-drugs-via-proximity-enabled-reactive-therapeutics/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Qingke Li,Chen Qu,Paul C. Klauser,Mengyuan Li,Feng Zheng,Nanxi Wang,Xiaoying Li,Qianbing Zhang,Xuemei Fu,Qian Wang,Yang Xu,Lei Wang |
| Citations | 215 |
| DOI | 10.1016/j.cell.2020.05.028 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.cell.com/article/S0092867420306231/pdf |
| OpenAlex ID | https://openalex.org/W3036688874 |
| PMID | 32579975 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Qian Wang](https://scholariq.org/researchers/qian-wang/)

## Paper primary topic

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

## Paper topics

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.